{"id":28581,"date":"2026-05-13T09:08:52","date_gmt":"2026-05-13T16:08:52","guid":{"rendered":"https:\/\/magventure.com\/us\/?p=28581"},"modified":"2026-05-13T09:55:28","modified_gmt":"2026-05-13T16:55:28","slug":"magventure-go-portable-tms-system","status":"publish","type":"post","link":"https:\/\/magventure.com\/us\/magventure-go-portable-tms-system\/","title":{"rendered":"MagVenture Launches MagVenture Go\u2122 Portable TMS System to Enhance Clinical Flexibility"},"content":{"rendered":"
\n
\n
\n
\n
\n \n \n News\n<\/p>\n <\/div>\n

May 13th 2026<\/p>\n <\/div>\n

MagVenture Launches MagVenture Go\u2122 Portable TMS System to Enhance Clinical Flexibility<\/h1>\n <\/div>\n
\n \"MagVenture\n <\/div>\n <\/div>\n <\/div>\n<\/section>\n\n\n\n
\n

Alpharetta, GA \u2014 May 13, 2026<\/strong> \u2014 MagVenture, a global leader in non-invasive neuromodulation technology, today announced the launch of the MagVenture Go\u2122 Portable TMS system<\/strong>, a compact and mobile transcranial magnetic stimulation (TMS) solution designed to support flexible clinical workflows and evolving practice needs.<\/p>\n\n\n\n

The MagVenture Go\u2122 system delivers the proven capabilities of MagVenture TMS Therapy in a portable, self-contained format. Designed with scheduling flexibility and accessibility in mind, the system enables providers to integrate TMS more seamlessly into their clinical environments while maintaining established treatment standards.<\/p>\n\n\n\n

MagVenture Go\u2122 is built as a complete TMS and peripheral pain therapy (mPNS) system based on the well-established MagPro\u00ae R20 platform, housed within a durable rolling case, allowing for simplified transport and setup. The system supports both repetitive TMS (rTMS) and intermittent theta burst stimulation (iTBS) protocols and is cleared to support nine different coils for psychiatric and peripheral pain therapy applications, including the MMC-140-II, MCF-140, MCF-B65, MCF-B70, C-B70, RT-120-II, MMC-90, and MCF-125 coils.<\/p>\n\n\n\n

\u201cMagVenture Go\u2122 reflects our commitment to designing solutions that align with how clinics operate today,\u201d said Kerry Rome, Senior Vice President of Sales and Marketing, MagVenture Inc.<\/strong> \u201cProviders are looking for ways to optimize scheduling, improve operational efficiency, and expand access within their existing care models. This system was developed to support those needs\u2014delivering the flexibility of a portable platform without compromising on clinical capability.\u201d<\/p>\n\n\n\n

The introduction of MagVenture Go\u2122 reflects the company\u2019s mission to pioneer safe, effective, and reliable magnetic stimulation therapies while offering innovative and versatile solutions that help expand access to care. The system is engineered to support clinical environments that require greater mobility, including multi-site practices and settings where equipment may need to be transported between locations.<\/p>\n\n\n\n

MagVenture Go\u2122 may also serve as an accessible entry point for practices beginning to incorporate TMS or for clinics managing lower patient volumes, with options that can support adoption through a low monthly cost structure while maintaining the clinical standards associated with MagVenture systems.<\/p>\n\n\n\n

Key features of the MagVenture Go\u2122 system include:<\/p>\n\n\n\n